Immuneering Corp
NASDAQ:IMRX
Immuneering Corp
Depreciation & Amortization
Immuneering Corp
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
Immuneering Corp
NASDAQ:IMRX
|
Depreciation & Amortization
-$252.3k
|
CAGR 3-Years
-133%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Abbvie Inc
NYSE:ABBV
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Immuneering Corp's Depreciation & Amortization?
Depreciation & Amortization
-252.3k
USD
Based on the financial report for Dec 31, 2023, Immuneering Corp's Depreciation & Amortization amounts to -252.3k USD.
What is Immuneering Corp's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
-133%
Over the last year, the Depreciation & Amortization growth was -33%. The average annual Depreciation & Amortization growth rates for Immuneering Corp have been -133% over the past three years .